Autolus Therapeutics Plc (AUTL)

1.59 -0.11 (-6.47%) USD  |  NASDAQ  |  May 07, 12:58
More

Autolus Therapeutics SG&A Expense (TTM) : 131.95M for Dec. 31, 2025

SG&A Expense (TTM) Chart

View SG&A Expense (TTM) for AUTL.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View SG&A Expense (TTM) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

SG&A Expense (TTM) Range, Past 5 Years

View SG&A Expense (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

SG&A Expense (TTM) Benchmarks

View SG&A Expense (TTM) Benchmarks
Start Trial
Biodexa Pharmaceuticals Plc 6.375M
NuCana Plc 10.74M
Mereo BioPharma Group Plc 23.06M
Smith & Nephew plc 3.110B
Bicycle Therapeutics Plc 75.75M